Bexsero Uniunea Europeană - română - EMA (European Medicines Agency)

bexsero

gsk vaccines s.r.l. - exterior membrana veziculelor de neisseria meningitidis grup b (tulpina nz 98/254), recombinant neisseria meningitidis grup b fhbp proteină de fuziune, recombinant neisseria meningitidis grup b nada proteine, recombinant neisseria meningitidis grup b nhba proteină de fuziune - meningită, meningococică - vaccinuri meningococice - imunizarea activă împotriva bolilor invazive cauzate de tulpinile serogrup-b ale neisseria meningitidis.

Gardasil Uniunea Europeană - română - EMA (European Medicines Agency)

gardasil

merck sharp & dohme b.v.  - papilomavirus uman tip 6, proteina l1, papilomavirus uman tip 11 proteina l1, papilomavirus uman de tip 16 proteina l1, papilomavirus uman tip 18 proteina l1 - papillomavirus infections; uterine cervical dysplasia; condylomata acuminata; immunization - vaccinuri - gardasil este un vaccin utilizat la vârsta de 9 ani pentru prevenirea:leziuni genitale precanceroase (cervicale, vulvare și vaginale), premaligne leziunilor anale, cancer de col uterin și cancer anal cauzal legate de anumite oncogene de papilomavirus uman (hpv), tipurile;veruci genitale (condyloma acuminata) cauzal legate de anumite tipuri de hpv. vezi secțiunile 4. 4 și 5. 1 pentru informații importante privind datele care susțin această indicație. utilizarea gardasil ar trebui să fie în conformitate cu recomandările oficiale.

Silgard Uniunea Europeană - română - EMA (European Medicines Agency)

silgard

merck sharp dohme ltd - papilomavirus uman tip 6, proteina l1, papilomavirus uman tip 11 proteina l1, papilomavirus uman de tip 16 proteina l1, papilomavirus uman tip 18 proteina l1 - papillomavirus infections; uterine cervical dysplasia; condylomata acuminata; immunization - vaccinuri - silgard este un vaccin utilizat la vârsta de 9 ani pentru prevenirea:leziuni genitale precanceroase (cervicale, vulvare și vaginale), premaligne leziunilor anale, cancer de col uterin și cancer anal cauzal legate de anumite oncogene de papilomavirus uman (hpv), tipurile;veruci genitale (condyloma acuminata) cauzal legate de anumite tipuri de hpv. vezi secțiunile 4. 4 și 5. 1 pentru informații importante privind datele care susțin această indicație. utilizarea de silgard ar trebui să fie în conformitate cu recomandările oficiale.

Spikevax (previously COVID-19 Vaccine Moderna) Uniunea Europeană - română - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Nuvaxovid Uniunea Europeană - română - EMA (European Medicines Agency)

nuvaxovid

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Cervarix Uniunea Europeană - română - EMA (European Medicines Agency)

cervarix

glaxosmithkline biologicals s.a. - omului papillomavirus1 tip 16 proteina l1, papilomavirus uman tip 18 proteina l1 - papillomavirus infections; uterine cervical dysplasia; immunization - vaccinuri - cervarix este un vaccin pentru utilizare la vârsta de 9 ani pentru prevenirea premaligne leziunile ano-genitale (col uterin, vulvare, vaginal şi anal) şi tipuri de cancer de col uterin şi anal cauzal legate de anumite tipuri de papilomavirus uman (hpv) oncogenic. vezi secțiunile 4. 4 și 5. 1 pentru informații importante privind datele care susțin această indicație. utilizarea cervarix trebuie să fie în conformitate cu recomandările oficiale.

Innovax-ND-IBD Uniunea Europeană - română - EMA (European Medicines Agency)

innovax-nd-ibd

intervet international b.v. - celule asociate viu recombinant turcia herpesvirus (tulpina hvp360), exprimarea proteinei de fuziune a nd virus și vp2 proteine de ibd virus - aviare, virusul herpes (marek boala lui) + virusul bursitei infecțioase aviare (boala de gumboro) + virusul bolii de newcastle/paramixovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Vectormune FP ILT + AE Uniunea Europeană - română - EMA (European Medicines Agency)

vectormune fp ilt + ae

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - pui - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Innovax-ND-ILT Uniunea Europeană - română - EMA (European Medicines Agency)

innovax-nd-ilt

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologii pentru aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Prevexxion RN+HVT+IBD Uniunea Europeană - română - EMA (European Medicines Agency)

prevexxion rn+hvt+ibd

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pui - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.